EM · Tachyarrhythmias
Tachyarrhythmias in the emergency department
Also known as Tachycardia · SVT · Ventricular tachycardia · Atrial fibrillation
The ED tachyarrhythmias — the stability-first algorithm, the narrow-versus-broad-complex (QRS 120 ms) decision, the management of a regular narrow-complex SVT (vagal manoeuvres then adenosine 6-12-12 mg), a regular broad-complex rhythm assumed ventricular until proven otherwise (amiodarone if stable, cardioversion if unstable), atrial fibrillation, and the dangerous contraindication of atrioventricular-node blockers in pre-excited AF (Wolff-Parkinson-White). ACEM-primary, globally tagged.
Checked against its sources on 2 Sept 2026
Practise this topic
On this page
Study tools
Your progress
Saved on this device.
Target exams
Red flags
- An unstable tachyarrhythmia — hypotension, shock, syncope, ischaemic chest pain, acute heart failure, or altered consciousness — is cardioverted immediately, regardless of the rhythm
- A regular broad-complex tachycardia is ventricular tachycardia until proven otherwise — do NOT give verapamil, which can collapse a failing ventricle
- In pre-excited atrial fibrillation (Wolff-Parkinson-White, an irregular broad-complex rhythm with a delta wave), atrioventricular-node blockers — adenosine, verapamil, diltiazem, a beta-blocker, digoxin — are contraindicated; they preferentially block the AV node and accelerate conduction down the accessory pathway to ventricular fibrillation
- Adenosine is avoided in asthma (bronchospasm risk) and in high-grade heart block, and can cause a brief asystole — warn the patient and monitor continuously
- Torsades de pointes — a polymorphic broad-complex tachycardia with a twisting axis on a long QT — is treated with an intravenous magnesium bolus
Meet the patient
A 34-year-old man lands in the resus bay with two hours of sudden palpitations, dyspnoea and central chest tightness. He is diaphoretic and cool peripherally: BP 82 over 50, HR 224 and regular. The monitor shows a regular narrow-complex tachycardia with no visible P waves, QRS 90 ms.[1]
One question decides his next minute, and it is not "what rhythm is this?" — it is "is he unstable?" He is: the hypotension, the ischaemic-sounding chest tightness at a rate of 224, and the cool shut-down peripheries all meet the instability criteria. So his next action is synchronised cardioversion now, before any vagal manoeuvre or drug. The QRS width and the drug ladder are problems for the stable patient — and he is not it.[1]
References20ShowHide
- [1]Brugada J, Katritsis DG, Arbelo E, et al. 2019 ESC Guidelines for the management of patients with supraventricular tachycardiaThe Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC) Eur Heart J, 2020.PMID 31504425
- [2]Sert ET, Kokulu K, Yürük O, et al. Initial 12 mg Versus 6 mg Adenosine for Supraventricular Tachycardia in the Emergency Department Acad Emerg Med, 2026.PMID 42057249
- [3]Wyse DG, Waldo AL, DiMarco JP, et al. A comparison of rate control and rhythm control in patients with atrial fibrillation N Engl J Med, 2002.PMID 12466506
- [4]Van Gelder IC, Groenveld HF, Crijns HJ, et al. Lenient versus strict rate control in patients with atrial fibrillation N Engl J Med, 2010.PMID 20231232
- [5]Dorian P, Cass D, Schwartz B, Cooper R, Gelaznikas R, Barr A (ALIVE Investigators) Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation N Engl J Med, 2002.PMID 11907287
- [6]Kudenchuk PJ, Brown SP, Daya M, et al. Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Cardiac Arrest N Engl J Med, 2016.PMID 27043165
- [7]Levine JH, Massumi A, Scheinman MM, et al. Intravenous amiodarone for recurrent sustained hypotensive ventricular tachyarrhythmias. Intravenous Amiodarone Multicenter Trial Group J Am Coll Cardiol, 1996.PMID 8522712
- [8]Page RL, Joglar JA, Caldwell MA, et al. 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society J Am Coll Cardiol, 2016.PMID 26409258
- [9]Soar J, Perkins GD, Maconochie I, et al. European Resuscitation Council Guidelines for Resuscitation: 2018 Update - Antiarrhythmic drugs for cardiac arrest Resuscitation, 2019.PMID 30496838
- [10]Joglar JA, Chung MK, Armbruster AL, et al. 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines Circulation, 2024.PMID 38033089
- [11]Tzivoni D, Keren A, Banai S, et al. Terminology of torsades de pointes Cardiovasc Drugs Ther, 1991.PMID 1854659
- [12]Antunes E, Brugada J, Steurer G, Andries E, Brugada P The differential diagnosis of a regular tachycardia with a wide QRS complex on the 12-lead ECG: ventricular tachycardia, supraventricular tachycardia with aberrant intraventricular conduction, and supraventricular tachycardia with anterograde conduction over an accessory pathway Pacing Clin Electrophysiol, 1994.PMID 7991423
- [13]Gamberini L, Moro F, Dallari C Prehospital diagnosis and management of supraventricular tachycardia - a scoping review Scand J Trauma Resusc Emerg Med, 2026.PMID 41723483
- [14]Ohlow MA, Beierlein A, Müller S [Stable tachycardia with wide QRS complex in pre-hospital emergency medicine]. Dtsch Med Wochenschr, 2005.PMID 16294283
- [15]Sacchetti A, Williams J, Levi S Impact of emergency department management of atrial fibrillation on hospital charges West J Emerg Med, 2013.PMID 23447757
- [16]Matsuura C, Kato T, Koyama K Successful Management of Refractory Torsades De Pointes Due to Drug-Induced Long QT Syndrome Cureus, 2021.PMID 33880279
- [17]Xie Y, Li W, Meng Y Development and Validation of the GLORIA-AF Stroke Weighted Risk Score for Patients with Atrial Fibrillation Europace, 2026.PMID 42667264
- [18]Khan IA, Nair CK, Singh N Acute ventricular rate control in atrial fibrillation and atrial flutter Int J Cardiol, 2004.PMID 15336799
- [19]Australian and New Zealand Committee on Resuscitation (ANZCOR) Guideline 11.9 - Managing Acute Dysrhythmias ANZCOR, 2026.Source
- [20]Cardiac Arrhythmia Suppression Trial (CAST) Investigators Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction N Engl J Med, 1989.PMID 2473403